1. What is cardiogenic shock? National Heart, Lung, and Blood Institute Web site. Updated July 1, 2011. Accessed August 3, 2016.
  2. Warning signs of heart failure. American Heart Association Web site. Reviewed April 2015. Accessed August 3, 2016.
  3. Costanzo MR, Mills RM, Wynne J.. Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). Am Heart J. 2008;155(2):339-347. doi: 10.1016/j.ahj.2007.10.020.
  4. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235. Accessed August 3, 2016.
  5. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, MA: Little, Brown & Co; 1994:253-256.
  6. Heart failure. US National Library of Medicine, MedlinePlus Web site. Reviewed August 29, 20114. Accessed August 3, 2016.
  7. Goldstein D. Postcardiotomy Cardiogenic Shock: Pearls & Pitfalls. Presented at: AATS 94th Annual Meeting; April 26, 2014-April 30, 2014; Toronto, ON, Canada. Accessed August 3, 2016.
  8. Vigilance DW, Oz MC. Strategies for management of postcardiotomy cardiogenic shock following valvular heart surgery. Adv Cardiol. 2004;41:140-149.
  9. Types of heart failure. American Heart Association Web site. Reviewed April 6, 2015. Accessed August 3, 2016.
  10. Jugdutt B, Butler C.Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support. J Am Coll Cardiol. 2007;49(11):1175-1177.
  11. Kawashima D1, Gojo S, Nishimura T, et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 2011;57(3):169-176. doi: 10.1097/MAT.0b013e31820e121c.
  12. Pieri M, Contri R, Winterton D, et al. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience. BMC Cardiovasc Disord. 2015;15:126. doi: 10.1186/s12872-015-0119-9.
  13. Maini B, Gregory D, Scotti DJ, Buyantseva L. Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: Cost-Effectiveness in the Emergent Setting. Catheter Cardiovasc Interv. 2014;83(6):E183-E192. doi: 10.1002/ccd.25247.
  14. Cheung A, Danter M, Gregory D. Comparative economic outcomes in cardiogenic shock patients managed with the minimally invasive Impella or extracorporeal life support [abstract]. J Am Coll Cardiol. 2012;60(17, Suppl B):B110. Abstract TCT-385. doi:10.1016/j.jacc.2012.08.413.
  15. Gregory D, Scotti DJ, de Lissovoy G, et al. A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention. Am Health Drug Benefits. 2013;6(2):88-99.
  16. What is hemodynamics. International Hemodynamic Society (IHS) Web site. Accessed August 4, 2016.
  17. What is heart failure? National Heart, Lung, and Blood Institute Web site. Updated June 22, 2015. Accessed August 4, 2016.